Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NL-OMON25635
NL-OMON25635CompletedNot Applicable

European Multicentre Randomised Controlled Clinical Trial: Heavy Silicone Oil versus Standard Silicone Oil as long Term Vitreous Tamponade (HSO-Study).

Not provided0 sites80 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
80
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Wong D, Van Meurs JC, Stappler T, Groenewald C, Pearce IA, McGalliard JN, Manousakis E, Herbert EN. A pilot study on the use of a perfluorohexyloctane/silicone oil solution as a heavier than water internal tamponade agent. Br J Ophthalmol. 2005; 89(6):662-5. PMID: 15923496

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •1. Ablatio retinae with PVR;
  • •2. Giant tear below 10-12 h.

Exclusion Criteria

  • •1. Defects above 10-2 h;
  • •2. Proliferative diabetic retinopathy;

Investigators

Sponsor
Not provided

Similar Trials

Completed
Not Applicable
European multicentre randomised controlled clinical trial: Heavy Silicone Oil (HSO) versus standard silicone oil as long term vitreous tamponadeRetinal detachment, proliferative vitreoretinopathyEye DiseasesOther retinal disorders
ISRCTN47399029Rotterdam Eye Hospital (Oogziekenhuis Rotterdam) (The Netherlands)80
Not yet recruiting
Not Applicable
Pegvisomant-toevoeging bij patiënten met acromegalie: Effect op symptomen, kwaliteit van leven en insuline-gevoeligheid.Acromegaly, pituitary disease, normal IGF1, somatostatin analogues, Pegvisomant
NL-OMON24812Erasmus University MCDept. of MedicinePO Box 20403000 CA Rotterdam NLTel: +31 10 703 286260
Completed
Not Applicable
Randomised prospective European Multicenter Oscillator Acute Respiratory Distress Syndrome (ARDS) Trial
ISRCTN24242669SensorMedics (USA)61
Recruiting
Not Applicable
A prospective, randomised controlled multi-centre trial comparing in-hospital treatment and early assisted discharge for exacerbations of Chronic Obstructive Pulmonary Disease (COPD).Chronic Obstructive Pulmonary Disease (COPD), exacerbation treatment, early assisted discharge, cost-effectiveness. patient preference.
NL-OMON23731niversity Maastricht (UM), CAPHRI instituteiMTA, Erasmus MC Rotterdam235
Completed
Not Applicable
A European randomised multicentre study of interferon alpha-2b versus no treatment after intensive therapy and Autologous hematopoeitic Stem Cell Transplantation (ASCT) for relapsing lymphoma patientsymphoma (Hodgkin's), Lymphoma (non-Hodgkin's)LymphomaCancer
ISRCTN46751362Schering-Plough Ltd (UK)